What Drives Drug Pricing?
Setup
High drug prices have seized headlines, angered patient advocates, and prompted congressional hearings. Many causes have been suggested — among them, a fragmented pharmaceutical market that limits competition, the quest for profits (whether to fund expensive R&D or otherwise), and government regulations that bar Medicare from negotiating prices. Harder to find are solutions for patients who cannot afford their therapies. Venture capitalists may be a unique leverage point on the system because their investments can encourage risk-taking and the development of novel, high-impact medicines, shifting the locus of industry’s search for rewards. How do we encourage a drug-development system that innovates, while keeping lifesaving therapies affordable?
Speakers
-
Steve ClemonsEditor in Chief, AtlanticLIVE; Washington Editor at Large, The Atlanti... -
Gregory GloverPrincipal, Pharmaceutical Law Group -
Anula JayasuriyaManaging Director and Founder, EXXclaim Capital; Vice President of Cor... -
Aaron KesselheimAssociate Professor of Medicine, Harvard Medical School; Director, Pro...
- 2017 Health
- Health
Explore More
Health
From the Supreme Court's ruling on abortion rights to public health's role in addressing gun violence to the devastating human toll of the war in Ukraine, this year's Aspen Id...
In America, millions of people struggle with mental health including depression, anxiety, and more — all further exacerbated by living through a pandemic. The National Allianc...
What do Sherlock Holmes and an internist have in common? Meet Lisa Sanders, the doctor reimagining the way medical mysteries are diagnosed. She explains why providers struggl...
The "Great Resignation" has impacted nursing and created a healthcare crisis for us all. What can be done to drive real change and create a supportive work environment where n...
From the "War on Cancer" to the "Cancer Moonshot", extraordinary progress continues to be made in the prevention, diagnosis, and treatment of cancer. Research is driving life-...
In the wake of transformative biopharmaceutical innovation and breakthroughs, Americans need a health care system that ensures these life-saving breakthroughs reach all patien...
A silent epidemic of chronic illnesses, including autoimmune disease, post-treatment Lyme disease syndrome, and long COVID, afflicts tens of millions of Americans. Best-sellin...
Achieving vaccine equity requires authentically communicating with and listening to all communities. As healthcare leaders, we must go where the community is to hear their sto...
Health workers often face grueling working conditions. They regularly confront trauma, work long hours, are exposed to physical danger, and must keep pace with the demands of...
Today's kids are coming of age against a backdrop of political, social, technological, and economic upheaval. While these circumstances are shaping a precocious generation tha...
For people with post-traumatic stress disorder, therapy assisted by the drug MDMA may provide lasting relief, with a new way of seeing their trauma and themselves. Rachel Yehu...
Monkeypox has now been declared a public health emergency in the US and a global emergency by the World Health Organization. What do we know about this virus and the current o...
